Compugen presents COM701 ovarian cancer trial poster at ESMO
Go back to Compugen presents COM701 ovarian cancer trial poster at ESMO| Compugen Ltd (NASDAQ: CGEN) | Delayed: 2.33 -0.09 (3.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.42 | 52 Week High | $7.79 | |||
| Open | $2.39 | 52 Week Low | $4.32 | |||
| Day High | $2.40 | P/E | N/A | |||
| Day Low | $2.33 | EPS | $-0.36 | |||
| Volume | 138,414 | |||||

